Hantavirus Outbreak Guide: Symptoms, Prevention, and Facts
The recent media coverage of a hantavirus outbreak on a cruise ship is causing widespread panic. I get it. COVID-19 was only six years ago, and many of us carry an understandable degree of trauma from that experience. The sensationalism being used to report the current outbreak is feeding into those fears.
This week, I want to talk to you about hantavirus. What kind of virus is it? How does it spread? Who is at risk? What do symptoms look like? How is it treated, and how can you protect yourself? I am also going to address some of the misinformation making the rounds. My hope is that after reading this, I can quell your fears with the evidence.
What is Hantavirus?
Hantavirus is a single-stranded RNA virus first discovered in 1976. It became more widely known after a genetically distinct form was identified in 1993 during an outbreak in the southwestern United States.1 Rodents are the primary natural hosts and are believed to be persistently asymptomatically infected. Infected rodents secrete viral particles in their saliva, urine, and feces.2 There are an estimated 200,000 cases of hantavirus annually worldwide, with a reported mortality rate ranging from 1% to 38%.3 More than 50 species have been identified, six of which are known to be pathogenic to humans: Hantaan, Seoul, Dobrava-Belgrade, Puumala, Andes, and Sin Nombre.4 The Andes strain is the one identified in the current cruise ship outbreak.
How Do You Get Hantavirus? Airborne vs Person-to-Person
The most common mode of transmission is inhalation of aerosolized viral particles shed through urine, feces, and saliva of infected rodents.1 The Andes strain is the only hantavirus with documented person-to-person spread. However, it is important to emphasize that the primary risk factor for person-to-person transmission is prolonged or close contact with a symptomatic individual.5 This risk increases further with sexual contact, exposure to saliva, and breastfeeding.6 The incubation period can last up to six weeks.1
To understand how contagious the Andes strain actually is, we must first discuss the R0 value. R0, pronounced “R-naught”, represents how many people one infected person will go on to infect. An R0 above 1 means a disease is at risk of spreading. A value below 1 means it is not. For context, measles has an R0 of 12 to 18. COVID-19 initially had an R0 of 2 to 3.
An epidemiologic analysis of the 33 patients identified in the 2018-2019 Epuyén, Argentina outbreak of the Andes strain identified an R0 value of 2.12, which decreased to 0.96 after control measures were implemented.5 The primary superspreading event was a party with approximately 100 guests. The infected individual was febrile and symptomatic and attended the party for more than 90 minutes. Five individuals seated close to this person were infected. A subsequent spread occurred at the funeral of one of those attendees, where the deceased’s symptomatic partner infected 10 additional individuals.5 This study confirmed the person-to-person spread of the Andes strain and that control measures work.
What Are Hantavirus Symptoms?
Hantavirus can present as something as mild as a fever and flu-like symptoms. It can also be deadly. To understand why, it is important to know how the virus works.
Hantavirus primarily attacks the cells lining the small blood vessels and capillaries of the lungs, kidneys, heart, liver and spleen. This causes fluid to leak into surrounding tissues. The virus also disrupts platelet activity, leading to clotting abnormalities, and disrupts other blood cells of the immune system.1
The more severe cases result from one of two syndromes. Hantavirus cardiopulmonary syndrome (HCPS) occurs primarily in the Americas. Hemorrhagic fever with renal syndrome (HFRS) occurs primarily in Europe and Asia.1 Both begin with fever, fatigue, joint pain, and muscle aches. Gastrointestinal symptoms such as nausea, vomiting, and abdominal pain can develop in one third of cases.2 HCPS then progresses to severely low oxygen levels, pulmonary edema, and shock, with a mortality rate as high as 50%.5 HFRS presents after the initial febrile phase with back pain, rash, bleeding, blurred vision, and/or kidney failure, and carries a lower mortality rate of up to 15%.1 The Andes strain causes HCPS, which is responsible for the fatalities in the current cruise ship outbreak.
Is There a Hantavirus Cure? How is it Treated?
There is no specific antiviral or immunomodulatory treatment available for hantavirus.1 The mainstays of treatment are supportive care with mechanical ventilation, extracorporeal membrane oxygenation, and other therapies focusing on oxygenation, hemodynamic stability, and fluid management.1,2,7
There is a small body of evidence suggesting some benefit with convalescent plasma in Andes strain infections, and promising early data supporting ribavirin and favipiravir in post-exposure prophylaxis.1
How to Safely Protect Yourself
Since the most common route of infection is exposure to viral particles in infected rodent urine, feces, and saliva, avoiding contact with those particles effectively reduces the risk of infection. This can be done by keeping wild rodents out of homes, cabins, and other enclosed spaces. When cleaning infested areas, wearing personal protective equipment such as masks and gloves along with disinfectant or bleach cleaning solutions further reduces risk. Dry sweeping contaminated areas promotes the aerosolization of viral particles and should be avoided.7
The 2026 Cruise Ship Outbreak: Why This Will Not Become a Pandemic
It’s hard not to get swept up in the hanta-hype when the media coverage is framing this cruise ship outbreak as the beginning of a worldwide outbreak. The fact is that we are not even close.
The cruise ship passengers are under surveillance, and some are under quarantine. That matters because the Andes strain requires close, prolonged contact to spread. With control measures in place, the R0 has already dropped below 1. That means the virus is not spreading.
Once this passes, and it will, we will return to our baseline. There are only about 20 to 40 cases of hantavirus reported annually in the United States, and none of them are caused by the Andes strain. The Andes strain is endemic to Argentina and Chile, where approximately 90 to 160 cases occur per year. There are no documented cases of the Andes virus in the United States. The average American has a risk of essentially zero of acquiring Andes in the US.
Just to put things in perspective, the current cruise ship outbreak is not even the largest Andes outbreak on record. The 2018-2019 Epuyén outbreak in Argentina involved 33 confirmed cases, was contained to a small region, and did not become a pandemic. My guess is most people never heard about it due to lack of media coverage.
Lastly, cruise ships are among the most efficient environments on Earth for transmitting infection. You are in close quarters with strangers at every meal, every excursion, and every embarkation. Buffet-style dining, shared surfaces and crowded corridors are the perfect transmission environment. Entire ships routinely get norovirus. This was 11 people with hantavirus on a vessel carrying 149 people. Given the conditions, the more remarkable story is how contained the outbreak actually was.
Fact-Checking Hantavirus Misinformation and Online Myths
It makes me sad that people exploit the fear of others for financial gain. And yet here we are. The same playbook is being used for this outbreak that was used during COVID-19, so let us go through it.
Does Ivermectin Treat Hantavirus? (The Viral RNA Claim)
Ivermectin is a well-established antiparasitic medication that works by binding to glutamate-gated chloride channels in the nerve and muscle cells of parasites, causing paralysis and death of the parasite. While viruses do not have glutamate-gated chloride channels, scientists discovered that ivermectin can also block protein transport channels that certain RNA viruses use to infect cells in cell culture studies.8 This effect was again demonstrated in a 2020 study using cell cultures infected with SARS-CoV-2.9 That is when ivermectin entered the mainstream conversation as a potential antiviral, and the claims have never gone away. But there are serious problems with using ivermectin as an antiviral.
First, the doses required for ivermectin to effectively produce any antiviral effect in cell cultures are toxic to humans. At those concentrations, ivermectin would indiscriminately destroy healthy cells that the human body needs to function.10 Second, a 2025 study found that ivermectin interferes with the viral assays used to measure antiviral activity, raising the question of whether ivermectin was actually inhibiting the virus or simply destroying the cells the virus was growing in.11 Third, multiple randomized controlled trials and a Cochrane meta-analysis demonstrated that ivermectin failed to improve outcomes in COVID-19, further solidifying that ivermectin is a worthless antiviral medication at doses humans can tolerate.12-15 Lastly, there are no studies evaluating ivermectin against hantavirus specifically.
I hope this puts the ivermectin-hantavirus claim to bed, along with any other ivermectin-RNA virus claim. Ivermectin – great for worms. Ivermectin – worthless for viruses.
Can High-Dose Vitamin D and Zinc Prevent Hantavirus?
Are there benefits to vitamin D and zinc? Yes. I’ve discussed them in prior posts, and I just so happen to take a vitamin D3/K2 supplement because my own levels are low.
But the doses being circulated online right now are dangerous. Vitamin D is a fat-soluble vitamin, which means your body does not simply excrete the excess the way it does with water-soluble vitamins like vitamin C. Fat-soluble vitamins (A, D, E, and K) are processed through the liver and excreted slowly, which means they accumulate, and toxicity is a real risk. 10,000 IU of vitamin D daily is excessive. A loading dose of 100,000 IU for three days is reckless. These doses can lead to very elevated calcium levels and abdominal pain, vomiting, confusion, kidney failure, pancreatitis, abnormal heart rhythms, and coma.16
While I am all for boosting our immune systems, I am not in favor of doing it in a way that puts you in the hospital.
Is Hantavirus the Next Global Pandemic?
I already addressed this above with data but let me be direct: the characteristics that make a virus pandemic-capable are high transmissibility, a large susceptible population, no available immunity, and sustained human-to-human spread across multiple regions. Hantavirus, including the Andes strain, only meets the lack of available immunity. The R0 under surveillance is below 1. Transmission requires prolonged close contact. There are no documented cases in the US. The outbreak is contained to a single vessel with known contacts under monitoring.
The fear is understandable. The pandemic label is not warranted.
Does Vinegar or Essential Oils Kill Hantavirus on Surfaces?
This one comes up every time there is an infectious disease in the news, and it is worth addressing directly. Vinegar and essential oils are not effective disinfectants against viruses. Vinegar is a dilute acetic acid solution with some antibacterial properties in certain concentrations, but it has no reliable antiviral activity and is not recognized by the CDC or EPA as an effective disinfectant.
For hantavirus specifically, the CDC recommends using a diluted bleach solution, one part bleach to nine parts water, or an EPA-registered disinfectant. Spraying surfaces with vinegar or diffusing essential oils into the air will not inactivate hantavirus particles. It will make your house smell nice, introduce potential endocrine disruptors, and give you a false sense of security, which in this context is the more dangerous outcome.
The TL:DR on Hantavirus
I get it. Hantavirus is scary. Some strains carry a very high mortality rate, and there is no specific antiviral treatment. But the likelihood of the average person contracting hantavirus from this cruise ship outbreak is exceedingly low.
Every spring, we open up our camper, and I am gloved and masked spraying everything down with disinfectant yelling about hantavirus. We live in the Northeast, where the incidence is rare, but that does not stop me from taking precautions. Unless you were on the MV Hondius, live in an endemic area, or spent time in an infested enclosed space without protective equipment, your risk is close to zero.
This is not something to panic about. It is a good reminder that the best protection against hantavirus, and most infectious diseases, is not a supplement protocol promoted by an influencer. It is understanding how the disease actually spreads and taking the straightforward, evidence-based steps to avoid it. And now, you know the facts.
Disclaimer: Even though I’m a doctor, I’m not your doctor and reading this blog does not establish a doctor–patient relationship. This information is intended for general educational purposes only and should not be taken as personalized medical advice. Always speak with your own healthcare provider before making decisions about your health.
References
- Vial PA, Ferrés M, Vial C, et al. Hantavirus in humans: a review of clinical aspects and management. Lancet Infect Dis. Sep 2023;23(9):e371-e382. doi:10.1016/s1473-3099(23)00128-7
- Hunter M, Saubidet IL, Amerio T, Leone MV. Case 15-2025: A 52-year-old man with fever, nausea, and respiratory failure. New England Journal of Medicine. 2025;392(20):2049-2057.
- Romeo MA, Tofani S, Lapa D, et al. Orthohantaviruses: An Overview of the Current Status of Diagnostics and Surveillance. Viruses. Apr 26 2025;17(5)doi:10.3390/v17050622
- Chen RX, Gong HY, Wang X, et al. Zoonotic Hantaviridae with Global Public Health Significance. Viruses. Aug 8 2023;15(8)doi:10.3390/v15081705
- Martínez VP, Paola ND, Alonso DO, et al. “Super-Spreaders” and Person-to-Person Transmission of Andes Virus in Argentina. New England Journal of Medicine. 2020;383(23):2230-2241. doi:doi:10.1056/NEJMoa2009040
- Ferrés M, Martínez-Valdebenito C, Henriquez C, et al. Viral shedding and viraemia of Andes virus during acute hantavirus infection: a prospective study. Lancet Infect Dis. Jul 2024;24(7):775-782. doi:10.1016/s1473-3099(24)00142-7
- Abdoler EA, Malani PN. What Is Hantavirus? JAMA. 2025;334(1):98-98. doi:10.1001/jama.2025.5014
- Wagstaff KM, Sivakumaran H, Heaton SM, Harrich D, Jans DA. Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus. Biochemical Journal. 2012;443(3):851-856.
- Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral research. 2020;178:104787.
- Yilmaz S, Göktaş B, Ateş İ, Çelik M. Ivermectin Toxicity in Humans and Animals: Clinical Spectrum, Mechanisms, and Management. Journal of Applied Toxicology. 2026;46(6):1856-1870. doi:https://doi.org/10.1002/jat.70166
- Eastman RT, Rusinova R, Herold KF, et al. Membrane Perturbations and Assay Interferences by Ivermectin Explain Its In Vitro SARS-CoV-2 Antiviral Activities and Lack of Translatability. J Med Chem. Oct 23 2025;68(20):20979-21002. doi:10.1021/acs.jmedchem.5c01610
- Naggie S, Boulware DR, Lindsell CJ, et al. Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial. JAMA. 2023;329(11):888-897. doi:10.1001/jama.2023.1650
- López-Medina E, López P, Hurtado IC, et al. Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: A Randomized Clinical Trial. JAMA. 2021;325(14):1426-1435. doi:10.1001/jama.2021.3071
- Lim SCL, Hor CP, Tay KH, et al. Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities: The I-TECH Randomized Clinical Trial. JAMA Internal Medicine. 2022;182(4):426-435. doi:10.1001/jamainternmed.2022.0189
- Popp M, Reis S, Schießer S, et al. Ivermectin for preventing and treating COVID‐19. Cochrane Database of Systematic Reviews. 2022;(6)doi:10.1002/14651858.CD015017.pub3
- Marcinowska-Suchowierska E, Kupisz-Urbańska M, Łukaszkiewicz J, Płudowski P, Jones G. Vitamin D Toxicity–A Clinical Perspective. Review. Frontiers in Endocrinology. 2018-September-20 2018;Volume 9 – 2018doi:10.3389/fendo.2018.00550